JENNIFER CAMPBELL: Open Payments
NPI 1508546219 · KIRKSVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 67 payments from 10 companies in 2025. Trend: 2023 $204 · 2024 $1,486 · 2025 $1,349
Food & beverage: $1,248Education: $101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $296 |
| Teva Pharmaceuticals USA, Inc. | 8 | $293 |
| Neurocrine BioSciences, Inc. | 19 | $252 |
| Axsome Therapeutics, Inc. | 5 | $158 |
| Otsuka America Pharmaceutical, Inc. | 2 | $130 |
| Alkermes, Inc. | 4 | $78 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Lundbeck LLC | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: VRAYLAR, INGREZZA, UZEDY, Auvelity, REXULTI, ARISTADA, Qelbree, ABILIFY ASIMTUFII.
Industry payments across MO — which companies pay providers there.
